Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Scientist wins prestigious fellowship
A scientist from the ICR and The Royal Marsden has received one of four prestigious Cancer Research UK Clinical Scientist Fellowships for his research into new ways to detect and treat advanced prostate cancer.
Fewer, Larger Radiotherapy Doses Prove Safe For Prostate Cancer Patients
Less overall radiotherapy, delivered in fewer but higher doses, is as safe as standard, lower doses for treating prostate cancer, according to new research.
Scientists Discover How To Beat Resistance To Standard Leukaemia Drug
ICR scientists have revealed a technique to kill chronic myeloid leukaemia (CML) cells that have stopped responding to a targeted drug, according to research published in Cancer Cell
Scientist Recognised with Cancer Charity’s Highest Honour
The ICR's Professor Mel Greaves has become the first scientist honoured with leading blood cancer charity Leukaemia & Lymphoma Research's highest award.
Topping out ceremony marks milestone for The Royal Marsden and the ICR
Progress on The Royal Marsden and the ICR's new Centre for Molecular Pathology in Sutton, Surrey, has reached a major milestone with a topping out ceremony this week.
Global Award for Prostate Cancer Blood Test Developer
A scientist from the ICR and The Royal Marsden, Dr Timothy Yap, has received an award for ongoing work developing a blood test to predict how prostate cancer patients will respond to treatment.
First Risk Genes Found for Bone Marrow Cancer
A team of scientists led by the ICR has shown for the first time that a person’s genes influences their risk of developing multiple myeloma, according to a paper publishing in the journal Nature Genetics.
First patients enrolled in personalised medicine project
Clinicians and scientists at The Royal Marsden and the ICR are taking part in a ground-breaking national project which could lead to personalised cancer treatment for individual patients.
Gene Profiling Has Improved - But Not Yet Personalised - Breast Cancer Treatment
Genetic profiling has revolutionised our understanding of breast cancer, but more work is needed before we can deliver truly personalised medicine to patients, Professor Jorge Reis-Filho from the ICR writes in the prestigious journal The Lancet.
ICR Scientists at Forefront of High-Tech Gene Sequencing Initiative
Three new projects will use the latest sequencing machines to unravel the genetic secrets behind a range of cancers.
Skin Cancer Drug Development Boosted with £3m Grant
The ICR and The Royal Marsden are to progress into patient trials an experimental drug to combat the most deadly form of skin cancer. The BRAF-inhibitor has the potential to treat more sub-types of malignant melanoma than any other targeted treatments for this cancer.
ICR drug discovery highlighted for patient impact
Drug discovery research by ICR scientists has been singled out by a leading cancer journal for the current and future impact it is having on patients, and will be the subject of a presentation at an international cancer conference.